GSK has announced a significant acquisition, reaching a deal worth $950 million to purchase 35Pharma, a Canadian biopharmaceutical company with a focus on developing therapies for lung diseases linked to
All posts tagged in Luke Miels
2Articles
Speculation surrounding a potential merger between GlaxoSmithKline and AstraZeneca has gained traction as GSK’s leadership undergoes a transition. Analysts recently suggested that the appointment of Luke Miels as GSK’s new
